Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02877732 · ClinicalTrials.gov registry record · NA
EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 2
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT02877732: Clinical Trial NA study, sponsored by Stanford University.
NCT02877732 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02877732, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
This is a prospective multi-center cohort feasibility and exploratory study.
Interventions
- DEVICE EYE-SYNC eye-tracking
- OTHER SCAT-3 subtests
- OTHER DEM
- OTHER Simple Reaction Time subtest of ANAM-SRT
- OTHER Level of Alertnesss
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2016-07 |
| Est. Completion | 2017-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02877732
The ClinicalTrials.gov registry entry for NCT02877732 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which EYE-SYNC eye-tracking is the first listed.
NCT02877732 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02877732 about?
NCT02877732 is a clinical study titled "EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 2". This is a prospective multi-center cohort feasibility and exploratory study.
What is the current status of trial NCT02877732?
This trial is currently terminated. It is a NA study. The enrollment target is 12 participants. The study started on 2016-07. Estimated completion is 2017-04.
What interventions are being tested in trial NCT02877732?
The interventions under investigation include: EYE-SYNC eye-tracking (DEVICE), SCAT-3 subtests (OTHER), DEM (OTHER), Simple Reaction Time subtest of ANAM-SRT (OTHER), Level of Alertnesss (OTHER).
Who is sponsoring clinical trial NCT02877732?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.